Mokhtar Ali M, Badawy Ahmed A
Cairo University, Department of Anesthesia, Cairo, Egypt.
Cairo University, Department of Anesthesia, Cairo, Egypt.
Braz J Anesthesiol. 2018 Jan-Feb;68(1):57-61. doi: 10.1016/j.bjan.2017.03.009. Epub 2017 Jul 25.
Post-extubation laryngospasm is a dangerous complication that should be managed promptly. Standard measures were described for its management. We aimed to compare the efficacy of propofol (0.5 mg.kg) vs. lidocaine (1.5 mg.kg) for treatment of resistant post-extubation laryngospasm in the obstetric patients, after failure of the standard measures.
This study was conducted over 2 years on all obstetric patients scheduled for cesarean delivery. Post-extubation laryngospasm was initially managed with a standard protocol (removal of offending stimulus, jaw thrust, positive pressure ventilation with 100% oxygen). When this protocol failed, the tested drug was the second line (lidocaine in the first year and propofol in the second year). Lastly, succinylcholine was used when the tested drug failed.
In lidocaine group, 5% of parturients developed post-extubation laryngospasm, 31.9% of them were successfully treated via standard protocol, and 68.1% required lidocaine treatment. Among these, 65.6% of patients treated with lidocaine responded successfully and 34.4% required succinylcholine to relieve laryngospasm. In propofol group, 4.7% of parturients developed post-extubation laryngospasm, 30.1% of them were successfully treated via standard protocol, and 69.9% required propofol treatment. Among these, 82.8% of patients treated with propofol responded successfully and 17.2% required succinylcholine to relieve laryngospasm.
Small dose of propofol (0.5 mg.kg) is marginally more effective than lidocaine (1.5 mg.kg) for the treatment of resistant post-extubation laryngospasm in obstetric patients, after failure of standard measures and before the use of muscle relaxants.
拔管后喉痉挛是一种危险的并发症,应及时处理。已描述了其处理的标准措施。我们旨在比较丙泊酚(0.5mg/kg)与利多卡因(1.5mg/kg)在标准措施失败后治疗产科患者难治性拔管后喉痉挛的疗效。
本研究对所有计划行剖宫产的产科患者进行了2年。拔管后喉痉挛最初采用标准方案处理(去除刺激物、下颌前推、100%氧气正压通气)。当该方案失败时,受试药物作为二线用药(第一年为利多卡因,第二年为丙泊酚)。最后,当受试药物失败时使用琥珀胆碱。
在利多卡因组,5%的产妇发生拔管后喉痉挛,其中31.9%通过标准方案成功治疗,68.1%需要利多卡因治疗。在这些患者中,65.6%接受利多卡因治疗的患者反应成功,34.4%需要琥珀胆碱来缓解喉痉挛。在丙泊酚组,4.7%的产妇发生拔管后喉痉挛,其中30.1%通过标准方案成功治疗,69.9%需要丙泊酚治疗。在这些患者中,82.8%接受丙泊酚治疗的患者反应成功,17.2%需要琥珀胆碱来缓解喉痉挛。
在标准措施失败且在使用肌肉松弛剂之前,小剂量丙泊酚(0.5mg/kg)治疗产科患者难治性拔管后喉痉挛的效果略优于利多卡因(1.5mg/kg)。